s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
SEC STAFF LETTER
Filing
Filed
Wednesday, March 17, 2021
Accession number
9999999997-21-001235
Documents
filename1.pdf
REDACTED EXHIBIT
On sec.gov
Filing index
All files
Complete submission text
SGML header